Medicine, 2026 Osteochondrosis and osteomalacia are distinguished by inflammatory factors and metabolites Chen J., Liu Y., Chen J. et al. Olink Target 96OrthopedicsPathophysiologyPatient StratificationPlasma | | | | |
Cancer, 2026 T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer Shan Y., Ding B., Ji F. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Cytotherapy, 2026 Comparative Profiling of ASC Products Following Harvest with DisoNNex and TrypLE Johansen E., Bangsgaard S., Lethager L. et al. Olink Target 96Wider Proteomics StudiesTechnical EvaluationCell Lysate | | | | |
Medicina, 2026 Explorative Insights into Local Immune Response to BK Virus—A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts Michnowska A., Wojciuk B., Reus P. et al. Olink Target 96Infectious DiseasesNephrologyPathophysiologyUrine | | | | |
Medicina, 2026 Explorative Insights into Local Immune Response to BK Virus—A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts Michnowska A., Wojciuk B., Reus P. et al. Olink Target 96Infectious DiseasesNephrologyPathophysiologyUrine | | | | |
Nature Genetics, 2026 Aberrant cellular communities underlying disease heterogeneity in chronic obstructive pulmonary disease Zhang Y., Wei H., Nouws J. et al. Olink Explore HTRespiratory DiseasesPathophysiologyPlasma | | | | |
International Journal of Surgery, 2026 Multi-omics analysis identifies TBCB as a therapeutic target in sepsis-induced liver injury Ma X., Peng Z., Lei K. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesHepatologyPathophysiologyPlasma | | | | |
Nature Communications, 2026 Cross-ancestry comparison of aptamer and antibody protein measures Nicholas J., Katz D., Tahir U. et al. Olink Explore 3072/384Wider Proteomics StudiesTechnology EvaluationPlasma | | | | |
Nature Communications, 2026 Longitudinal plasma proteomic signatures of elite and viremic spontaneous HIV controllers Vadaq N., Groenendijk A., dos Santos J. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyPatient StratificationPlasma | | | | |
GigaScience, 2026 High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases Li Y., Zhai R., Yang Z. et al. Olink Explore 3072/384Technical StudiesData SciencePlasma | | | | |
American Journal of Respiratory and Critical Care Medicine, 2026 Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung disease Maddali M., Pugashetti J., Pienkos S. et al. Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma | | | | |
Diabetologia, 2026 Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes Syreeni A., Dahlström E., Smyth L. et al. Olink Explore HTMetabolic DiseasesNephrologyPathophysiologyPlasma | | | | |
Kidney International Reports, 2026 Dulaglutide Effect on Proteins Associated With CKD Progression McFarlin B., Tye S., Satake E. et al. Olink FocusMetabolic DiseasesNephrologyPathophysiologyPlasma | | | | |
Investigative Ophthalmology & Visual Science, 2026 Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype Lv K., Peng J., Wang H. et al. Olink Target 96Metabolic DiseasesOphthalmologyPatient StratificationPlasmaVitreous Humor | | | | |
Kidney International, 2026 Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1q Sendtner G., Miranda J., Naumann P. et al. Olink Explore 3072/384NephrologyPathophysiologyPlasma | | | | |
Advanced Science, 2026 Caspase‐3/GSDME‐Mediated Trophoblast Pyroptosis and Reciprocal Macrophage Polarization Contribute to Inflammation in Early‐Onset Preeclampsia Huang B., Deng W., Bi S. et al. Olink Explore 3072/384ObstetricsPathophysiologyPlasma | | | | |
Advanced Healthcare Materials, 2026 Uncovering the Adaptive Tumor Immunity Interactions from a Single‐Cell Level Liu T., Pang Y., Zhou C. et al. Olink Target 96 MouseOncologyTechnical EvaluationMouse Cell Supernatant | | | | |
Molecular Therapy, 2026 Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors Clubb J., Pakola S., Joenväärä S. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerum | | | | |
Molecular Therapy, 2026 Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors Clubb J., Pakola S., Joenväärä S. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerum | | | | |
Signal Transduction and Targeted Therapy, 2026 Multiomics Mendelian randomization identifies serpin family G member 1 as a chronic obstructive pulmonary disease modulator Yi E., Cui J., Wang H. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma | | | | |